Quick Takeaways
- EcoR1 Capital, LLC filed SCHEDULE 13D for iTeos Therapeutics, Inc. Common Stock (ITOS).
- Disclosed ownership: 28%.
- Date of event: 15 May 2025.
EcoR1 Capital, LLC - 15 May 2025 SCHEDULE 13D Report for iTeos Therapeutics, Inc. Common Stock (ITOS)
- Filing Manager
- EcoR1 Capital, LLC
- Reporting Manager
- EcoR1 Capital, LLC
- Symbol
- ITOS
- Shares outstanding
- 38,311,749 shares
- Disclosed Ownership
- 10,688,978 shares
- Ownership
- 28%
- Form type
- SCHEDULE 13D
- Filing time
- 16 May 2025, 19:22:17 UTC
- Date of event
- 15 May 2025
- Previous filing
- 13 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"EcoR1 Capital, LLC disclosed 28% ownership in iTeos Therapeutics, Inc. Common Stock (ITOS) on 15 May 2025."
What Changed
- Previous schedule filing date: 13 May 2025.
- Current filing was accepted on 16 May 2025, 19:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 28% | 10,688,978 | 0 | 10,688,978 | 0/s/ Oleg Nodelman | Title/Manager | 0001587114 |
| Oleg Nodelman | 28% | 10,688,978 | 0 | 10,688,978 | /s/ Oleg Nodelman | Reporting Person | 0001454385 |
| EcoR1 Capital Fund Qualified, L.P. | 26% | 10,020,210 | 0 | 10,020,210 | /s/ Oleg Nodelman | Manager of the General Partner, EcoR1 Capital, LLC | 0001598292 |